Author:
Benoni Roberto,Campagna Irene,Moretti Francesca,Tardivo Stefano
Abstract
Abstract
Objective
Given the human and economic cost of the COVID-19 pandemic, protecting healthcare workers (HCW) and ensuring continuity of care is critical. The aim of this study is to evaluate the cost-effectiveness of different strategies to ascertain COVID-19 recovery in HCWs.
Methods
Data were collected from the hospital health surveillance program on HCWs at the University Hospital of Verona between 29/02/2020 and 14/04/2021. The diagnosis of SARS-CoV-2 infection and the assessment of the recovery were made through RT-PCR on oro-nasopharyngeal swab-sample. Recovery time and probability were estimated through Kaplan–Meier estimate. For each recovery assessment strategy costs (laboratory diagnostics and human resources), expressed in local currency (euro—€), and working days saved (WDS—effectiveness) were estimated. A decision-tree was created where each knot was a time point scheduled by the different recovery assessment strategies. A Monte Carlo simulation method was used, and probabilistic sensitivity analysis assessed the effect of input uncertainty.
Results
In the study period 916 (9.9%) HCWs tested positive. Recovery time through symptom-based strategy (21 days 0.95 CI 16–24) was significantly lower compared to swab-based one (25 days 0.95 CI 23–28, p < 0.001). The swab-based strategy was dominated by all symptoms-based ones. Symptoms-based with a swab on days 14 and 17 had an ICER of 2 €/WDS and 27 €/WDS compared to the one scheduled on days 10 and 17 and with only one swab on the 17th day.
Conclusions
Scheduling swabs on days 14 and 17 in a symptom-based strategy was the most cost-effective, saving 7.5 more working days than the standard one with swabs on days 10 and 17.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Protezione Civile. COVID-19 Situazione Italia. https://opendatadpc.maps.arcgis.com/apps/dashboards/b0c68bce2cce478eaac82fe38d4138b1 (2021). Accessed 06 Dec 2021.
2. Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W, Mehta RS, Warner ET, Sikavi DR, Lo CH, Kwon S, Song M, Mucci LA, Stampfer MJ, Willett WC, Eliassen AH, Hart JE, Chavarro JE, Rich-Edwards JW, Davies R, Capdevila J, Lee KA, Lochlainn MN, Varsavsky T, Sudre CH, Cardoso MJ, Wolf J, Spector TD, Ourselin S, Steves CJ, Chan AT, COronavirus Pandemic Epidemiology Consortium. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public health. 2020;5(9):e475–83. https://doi.org/10.1016/S2468-2667(20)30164-X.
3. World Health Organization (WHO). The impact of COVID-19 on health and care workers: a closer look at deaths. https://apps.who.int/iris/handle/10665/345300. 2021. Accessed 06 Dec 2021.
4. Istituto Superiore di Sanità (ISS). EpiCentro, dati della Sorveglianza integrata COVID-19 in Italia. https://www.epicentro.iss.it/coronavirus/sars-cov-2-dashboard. 2021. Accessed 26 Jan 2022.
5. Hanly P, Ahern M, Sharp L, Ursul D, Loughnane G. The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study. Eur J Health Econ. 2021. https://doi.org/10.1007/s10198-021-01351-8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献